Click for best price
Orthostatic Hypotension Drugs Market Size, Share 2023
The increasing prevalence of chronic diseases will also contribute to the growth of the OH drugs market. Orthostatic hypotension is associated with various neurodegenerative diseases, cardiovascular diseases, and diabetes.
This report aims to provide a comprehensive presentation of the global market for Orthostatic Hypotension Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orthostatic Hypotension Drugs. This report contains market size and forecasts of Orthostatic Hypotension Drugs in global, including the following market information:
The global Orthostatic Hypotension Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Orthostatic hypotension is difficult to treat with single-drug therapy because orthostatic stress varies as per the circumstances during the day. Moreover, most of the OH drugs are used to improve postural symptoms, standing time, and function instead of achieving upright normotension that may cause supine hypertension. These factors have boosted the use of a combination of various drugs, such as midodrine and fludrocortisone, midodrine and pyridostigmine, or midodrine and octreotide, for the treatment of symptomatic OH.
We surveyed the Orthostatic Hypotension Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orthostatic Hypotension Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Orthostatic Hypotension Drugs Market Segment Percentages, by Type, 2022 (%)
- Midodrine
- Northera (droxidopa)
- Fludrocortisone
- Other Drugs
Global Orthostatic Hypotension Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Orthostatic Hypotension Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Medical Research Institute
- Clinic
- Other
Global Orthostatic Hypotension Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Orthostatic Hypotension Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Orthostatic Hypotension Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Orthostatic Hypotension Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amneal Pharmaceuticals Inc.
- H. Lundbeck AS
- Mylan NV
- Novartis AG
- Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orthostatic Hypotension Drugs, market overview.
Chapter 2: Global Orthostatic Hypotension Drugs market size in revenue.
Chapter 3: Detailed analysis of Orthostatic Hypotension Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orthostatic Hypotension Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Orthostatic Hypotension Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Orthostatic Hypotension Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orthostatic Hypotension Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orthostatic Hypotension Drugs Overall Market Size
2.1 Global Orthostatic Hypotension Drugs Market Size: 2022 VS 2030
2.2 Global Orthostatic Hypotension Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orthostatic Hypotension Drugs Players in Global Market
3.2 Top Global Orthostatic Hypotension Drugs Companies Ranked by Revenue
3.3 Global Orthostatic Hypotension Drugs Revenue by Companies
3.4 Top 3 and Top 5 Orthostatic Hypotension Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orthostatic Hypotension Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orthostatic Hypotension Drugs Players in Global Market
3.6.1 List of Global Tier 1 Orthostatic Hypotension Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Orthostatic Hypotension Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Orthostatic Hypotension Drugs Market Size Markets, 2022 & 2030
4.1.2 Midodrine
4.1.3 Northera (droxidopa)
4.1.4 Fludrocortisone
4.1.5 Other Drugs
4.2 By Type - Global Orthostatic Hypotension Drugs Revenue & Forecasts
4.2.1 By Type - Global Orthostatic Hypotension Drugs Revenue, 2018-2023
4.2.2 By Type - Global Orthostatic Hypotension Drugs Revenue, 2024-2030
4.2.3 By Type - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orthostatic Hypotension Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Medical Research Institute
5.1.4 Clinic
5.1.5 Other
5.2 By Application - Global Orthostatic Hypotension Drugs Revenue & Forecasts
5.2.1 By Application - Global Orthostatic Hypotension Drugs Revenue, 2018-2023
5.2.2 By Application - Global Orthostatic Hypotension Drugs Revenue, 2024-2030
5.2.3 By Application - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Orthostatic Hypotension Drugs Market Size, 2022 & 2030
6.2 By Region - Global Orthostatic Hypotension Drugs Revenue & Forecasts
6.2.1 By Region - Global Orthostatic Hypotension Drugs Revenue, 2018-2023
6.2.2 By Region - Global Orthostatic Hypotension Drugs Revenue, 2024-2030
6.2.3 By Region - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Orthostatic Hypotension Drugs Revenue, 2018-2030
6.3.2 US Orthostatic Hypotension Drugs Market Size, 2018-2030
6.3.3 Canada Orthostatic Hypotension Drugs Market Size, 2018-2030
6.3.4 Mexico Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Orthostatic Hypotension Drugs Revenue, 2018-2030
6.4.2 Germany Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.3 France Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.4 U.K. Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.5 Italy Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.6 Russia Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Orthostatic Hypotension Drugs Market Size, 2018-2030
6.4.8 Benelux Orthostatic Hypotension Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Orthostatic Hypotension Drugs Revenue, 2018-2030
6.5.2 China Orthostatic Hypotension Drugs Market Size, 2018-2030
6.5.3 Japan Orthostatic Hypotension Drugs Market Size, 2018-2030
6.5.4 South Korea Orthostatic Hypotension Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Orthostatic Hypotension Drugs Market Size, 2018-2030
6.5.6 India Orthostatic Hypotension Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Orthostatic Hypotension Drugs Revenue, 2018-2030
6.6.2 Brazil Orthostatic Hypotension Drugs Market Size, 2018-2030
6.6.3 Argentina Orthostatic Hypotension Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, 2018-2030
6.7.2 Turkey Orthostatic Hypotension Drugs Market Size, 2018-2030
6.7.3 Israel Orthostatic Hypotension Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Orthostatic Hypotension Drugs Market Size, 2018-2030
6.7.5 UAE Orthostatic Hypotension Drugs Market Size, 2018-2030
7 Orthostatic Hypotension Drugs Companies Profiles
7.1 Amneal Pharmaceuticals Inc.
7.1.1 Amneal Pharmaceuticals Inc. Company Summary
7.1.2 Amneal Pharmaceuticals Inc. Business Overview
7.1.3 Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Major Product Offerings
7.1.4 Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue in Global Market (2018-2023)
7.1.5 Amneal Pharmaceuticals Inc. Key News & Latest Developments
7.2 H. Lundbeck AS
7.2.1 H. Lundbeck AS Company Summary
7.2.2 H. Lundbeck AS Business Overview
7.2.3 H. Lundbeck AS Orthostatic Hypotension Drugs Major Product Offerings
7.2.4 H. Lundbeck AS Orthostatic Hypotension Drugs Revenue in Global Market (2018-2023)
7.2.5 H. Lundbeck AS Key News & Latest Developments
7.3 Mylan NV
7.3.1 Mylan NV Company Summary
7.3.2 Mylan NV Business Overview
7.3.3 Mylan NV Orthostatic Hypotension Drugs Major Product Offerings
7.3.4 Mylan NV Orthostatic Hypotension Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan NV Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Orthostatic Hypotension Drugs Major Product Offerings
7.4.4 Novartis AG Orthostatic Hypotension Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Orthostatic Hypotension Drugs Major Product Offerings
7.5.4 Pfizer Inc. Orthostatic Hypotension Drugs Revenue in Global Market (2018-2023)
7.5.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Orthostatic Hypotension Drugs Market Opportunities & Trends in Global Market
Table 2. Orthostatic Hypotension Drugs Market Drivers in Global Market
Table 3. Orthostatic Hypotension Drugs Market Restraints in Global Market
Table 4. Key Players of Orthostatic Hypotension Drugs in Global Market
Table 5. Top Orthostatic Hypotension Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Orthostatic Hypotension Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Orthostatic Hypotension Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Orthostatic Hypotension Drugs Product Type
Table 9. List of Global Tier 1 Orthostatic Hypotension Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orthostatic Hypotension Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Orthostatic Hypotension Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Orthostatic Hypotension Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Orthostatic Hypotension Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Amneal Pharmaceuticals Inc. Company Summary
Table 31. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Product Offerings
Table 32. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Amneal Pharmaceuticals Inc. Key News & Latest Developments
Table 34. H. Lundbeck AS Company Summary
Table 35. H. Lundbeck AS Orthostatic Hypotension Drugs Product Offerings
Table 36. H. Lundbeck AS Orthostatic Hypotension Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. H. Lundbeck AS Key News & Latest Developments
Table 38. Mylan NV Company Summary
Table 39. Mylan NV Orthostatic Hypotension Drugs Product Offerings
Table 40. Mylan NV Orthostatic Hypotension Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan NV Key News & Latest Developments
Table 42. Novartis AG Company Summary
Table 43. Novartis AG Orthostatic Hypotension Drugs Product Offerings
Table 44. Novartis AG Orthostatic Hypotension Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis AG Key News & Latest Developments
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Orthostatic Hypotension Drugs Product Offerings
Table 48. Pfizer Inc. Orthostatic Hypotension Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
List of Figures
Figure 1. Orthostatic Hypotension Drugs Segment by Type in 2022
Figure 2. Orthostatic Hypotension Drugs Segment by Application in 2022
Figure 3. Global Orthostatic Hypotension Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orthostatic Hypotension Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Orthostatic Hypotension Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orthostatic Hypotension Drugs Revenue in 2022
Figure 8. By Type - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 16. US Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 28. China Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Orthostatic Hypotension Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Orthostatic Hypotension Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Amneal Pharmaceuticals Inc. Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. H. Lundbeck AS Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan NV Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis AG Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Inc. Orthostatic Hypotension Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
